• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Neuropathol Exp Neurol . Safe autopsy procedures for COVID-19: Experience of one research center

tetano

Editor, Senior Moderator
J Neuropathol Exp Neurol


. 2025 Oct 13:nlaf118.
doi: 10.1093/jnen/nlaf118. Online ahead of print. Safe autopsy procedures for COVID-19: Experience of one research center

Madison P Cline[SUP] 1 [/SUP], Analisa M Stewart[SUP] 1 [/SUP], Anthony J Intorcia[SUP] 1 [/SUP], Jessica E Walker[SUP] 1 [/SUP], Courtney M Nelson[SUP] 1 [/SUP], Richard A Arce[SUP] 1 [/SUP], Michael J Glass[SUP] 1 [/SUP], Daisy Vargas[SUP] 1 [/SUP], Sanaria H Qiji[SUP] 1 [/SUP], Claryssa I Borja[SUP] 1 [/SUP], Spencer J Hemmingsen[SUP] 1 [/SUP], Addison N Krupp[SUP] 1 [/SUP], Rylee D McHattie[SUP] 1 [/SUP], Kayleigh N Martinez[SUP] 1 [/SUP], Jaclyn Papa[SUP] 1 [/SUP], Javon C Oliver[SUP] 1 [/SUP], Aryck Russel[SUP] 1 [/SUP], Katsuko E Suszczewicz[SUP] 1 [/SUP], Holly M Hobgood[SUP] 1 [/SUP], Monica Mariner[SUP] 1 [/SUP], Ileana Lorenzini[SUP] 1 [/SUP], Sidra Aslam[SUP] 1 [/SUP], Cecilia Tremblay[SUP] 1 [/SUP], Suet Theng Beh[SUP] 1 [/SUP], Lucia N Sue[SUP] 1 [/SUP], Thomas G Beach[SUP] 1 [/SUP], Geidy E Serrano[SUP] 1 [/SUP]



Affiliations
Abstract

In the early days of the 2019 coronavirus disease (COVID-19) pandemic, there were few published guidelines for safely performing autopsies of infected individuals. To limit the risk to autopsy personnel, major changes to our autopsy protocol were initiated. Between January 26, 2020 and February 28, 2022, the Arizona Study of Aging and Neurodegenerative Disorders and its Brain and Body Donation Program performed autopsies on 162 subjects; of these, 36 tested positive for SARS-CoV-2 on FDA-certified PCR tests; 2 were undiagnosed. A key protocol change was the use a heavy-duty clear polyethylene bag sealed at the subject's neck and saw handle for containment of bone saw-generated aerosols during skullcap removal. During this time period, there were 94 COVID-19 autopsy exposures involving 19 staff members with only 2 occurrences of a single autopsy team member testing positive for SARS-CoV-2 within 7 days of participation in a SARS-CoV-2-positive autopsy. During the same period, 9 autopsy personnel without temporal proximity to autopsy participation tested positive. This suggests that our revised protocols reduced any enhanced risk of SARS-CoV-2 infection to autopsy personnel beyond the risk within the community. Therefore, we recommend the use of our protocol for performing autopsies on subjects with health-threatening communicable conditions.

Keywords: COVID-19; PPE; SARS-CoV-2; autopsy.

 
Back
Top